Oliviero James F III

Avg. Two Year Performance

1057% Avg. Purchase Return
240% Compound
53% Avg. Sale Return
24% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return132%218%431%975%1057%
Purchase Success Rate2 of 22 of 22 of 22 of 22 of 2
Average Sale Return3%< 1%5%21%53%
Sale Success Rate16 of 2913 of 2912 of 2916 of 2916 of 29

Checkpoint Therapeutics, Inc.

Other » Other

CEO, President and Director, Director:

Holdings: 1.94M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Keryx Biopharmaceuticals Inc.

Drugs » Drug Manufacturers - Major

Chief Financial Officer:

Holdings: 209.41K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Nuvectis Pharma, Inc.

Other » Other

Director:

Holdings: 57.83K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--